# A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

> **NCT02345057** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 365 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** CS-3150
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02345057
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345057, "A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02345057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*